NevadaAB18683rd Regular Session (2025)HouseWALLET

AN ACT relating to pharmacy; authorizing a registered pharmacist to prescribe drugs and devices to treat certain health conditions and dispense a refill without the authorization of a practitioner, other than a pharmacist, under certain circumstances; authorizing a registered pharmacist to administer drugs; authorizing a registered pharmacist to engage in certain activity relating to laboratories and laboratory testing; and providing other matters properly relating thereto.

Sponsored By: David Orentlicher (Democratic)

Failed

BDR 54-344

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

5 provisions identified: 5 benefits, 0 costs, 0 mixed.

Local government plans cover pharmacist prevention

Local-government self-insurance plans must cover listed HIV-prevention drugs, related lab tests, and specified services from in-network pharmacists. This applies to plans delivered, issued for delivery, or renewed on or after January 1, 2024. Plans must pay participating pharmacists the rate paid to physicians, physician assistants, or advanced practice registered nurses for similar services. Plans can use reasonable rules to manage medical care.

More HIV and hepatitis Medicaid care

Beginning January 1, 2026, Nevada Medicaid must cover qualifying primary-care services to test for, prevent, or treat HIV or hepatitis C. Services qualify when Medicaid covers them from a specialist. Providers must work within their licensed scope or provide care safely and effectively with specialist consultation. Nevada's Medicaid plan must include the state's funding share for specified HIV-prevention lab testing and pharmacist services. Pharmacists receive the rate paid to physicians, physician assistants, or advanced practice registered nurses for similar services. Physician assistants and advanced practice registered nurses receive physician rates for the qualifying HIV and hepatitis C services.

More HIV prevention care from pharmacists

Beginning January 1, 2026, qualified Nevada pharmacists can perform lab tests needed for FDA-approved medicines that prevent HIV. They can also prescribe, dispense, and administer those medicines to the extent federal law allows. Pharmacists must meet Nevada pharmacy board requirements and follow its care protocol.

More medicines and refills from pharmacists

Beginning January 1, 2026, Nevada pharmacists can prescribe FDA-approved medicines and devices for previously diagnosed conditions or conditions that resolve themselves. They can also treat acute conditions diagnosed through simple lab tests classified as waived under federal rules. Pharmacists can give one refill without another prescriber's approval when stopping the medicine would harm the patient's health. This new authority excludes opioids and treatment for opioid use disorder. Non-opioid controlled drugs are allowed only in inpatient facilities, multidisciplinary outpatient teams, hospice or palliative care, or substance-use treatment programs. Within this authority, pharmacists can issue orders for, possess, and administer controlled drugs for legitimate medical care. Schedule II drugs for themselves, their spouse, or their children are barred except in emergencies. Pharmacists must follow Nevada pharmacy board requirements.

Pharmacists gain broader lab testing roles

Beginning January 1, 2026, Nevada pharmacists can order tests needed for FDA-approved drug therapy or other care within their licensed scope. They can perform simple tests classified as waived under federal rules. Blood sugar testing with FDA-approved home devices must follow Association of Diabetes Care and Education Specialists standards. Pharmacy board rules must set collection and testing procedures, without limiting samples to fingersticks or mouth or nose swabs. Nevada rules must also let registered pharmacists direct licensed exempt labs, even without a collaborative practice agreement. These labs cannot perform only HIV tests. Each test must be federally classified as waived or as a provider-performed microscopy procedure.

Sponsors & Cosponsors

Sponsor

  • David Orentlicher

    Democratic • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. (No further action taken.)

    6/3/2025House
  2. To committee.

    4/23/2025House
  3. From printer. To engrossment. Engrossed. First reprint.

    4/23/2025House
  4. To printer.

    4/21/2025House
  5. Rereferred to Committee on Ways and Means. Exemption effective.

    4/21/2025House
  6. Taken from General File.

    4/21/2025House
  7. Read second time. Amended. (Amend. No. 445.)

    4/21/2025House
  8. Placed on Second Reading File.

    4/21/2025House
  9. From committee: Amend, and do pass as amended.

    4/21/2025House
  10. Notice of eligibility for exemption.

    3/4/2025House
  11. From printer. To committee.

    2/5/2025House
  12. To printer.

    2/4/2025House
  13. Read first time.

    2/4/2025House
  14. Referred to Committee on Commerce and Labor.

    2/3/2025House
  15. Prefiled.

    2/3/2025House

Bill Text

Related Bills

Back to State Legislation